Wall Street Experts
| Wartość aktywów (mln USD): | 264 | |||||||||||
| Liczba spółek: | 31 | |||||||||||
| Stopa dywidendy: | 0.92 % | |||||||||||
| Opłata za zarządzanie:: | 0.5 % | |||||||||||
| Klasa aktywów: | Equity |
ISIN: US46137V6627
Wystawca ETF: Invescohttps://www.invesco.com/us/financial-products/etfs/product-detail?audienceType=Advisor&ticker=PJP
| Nazwa | Symbol | Klasa_aktywów | Wartość_aktywów | 5D | 1M | 3M | 6M | 2024 | 1R | 3L | 5L | 10L |
|---|
| Sektor | Udział % |
|---|---|
| Technologie Medyczne | 99.9 |
| Fundusz Inwestycyjny | 0.1 |
| Nazwa firmy | Symbol | Wartość | Udział % w portfelu | Ilość akcji |
|---|---|---|---|---|
| Gilead Sciences Inc | GILD | 12 670 944 | 5.3 | 118 144 |
| Amgen Inc | AMGN | 12 290 193 | 5.2 | 41 748 |
| Johnson & Johnson | JNJ | 12 158 981 | 5.1 | 79 346 |
| Abbott Laboratories | ABT | 12 072 546 | 5.1 | 97 015 |
| AbbVie Inc | ABBV | 12 067 707 | 5.1 | 64 547 |
| Merck & Co Inc | MRK | 11 743 085 | 4.9 | 144 140 |
| Pfizer Inc | PFE | 11 320 672 | 4.8 | 492 846 |
| Eli Lilly & Co | LLY | 10 788 200 | 4.5 | 14 614 |
| ANI Pharmaceuticals Inc | ANIP | 8 901 904 | 3.7 | 131 841 |
| Corcept Therapeutics Inc | CORT | 8 737 824 | 3.7 | 117 365 |
| Tarsus Pharmaceuticals Inc | TARS | 8 185 946 | 3.4 | 174 095 |
| Perrigo Co PLC | PRGO | 7 499 060 | 3.2 | 285 027 |
| Supernus Pharmaceuticals Inc | SUPN | 7 173 072 | 3.0 | 219 092 |
| Innoviva Inc | INVA | 7 064 786 | 3.0 | 398 690 |
| Collegium Pharmaceutical Inc | COLL | 7 016 877 | 3.0 | 249 356 |
| Bristol-Myers Squibb Co | BMY | 6 827 172 | 2.9 | 123 457 |
| Prestige Consumer Healthcare Inc | PBH | 6 817 312 | 2.9 | 82 285 |
| Pacira BioSciences Inc | PCRX | 6 615 609 | 2.8 | 286 390 |
| Amneal Pharmaceuticals Inc | AMRX | 6 239 568 | 2.6 | 845 470 |
| Biogen Inc | BIIB | 6 160 437 | 2.6 | 50 093 |
| Ligand Pharmaceuticals Inc | LGND | 6 029 760 | 2.5 | 60 558 |
| Liquidia Corp | LQDA | 6 001 944 | 2.5 | 465 267 |
| Amphastar Pharmaceuticals Inc | AMPH | 5 977 537 | 2.5 | 224 635 |
| United Therapeutics Corp | UTHR | 5 880 493 | 2.5 | 20 107 |
| Regeneron Pharmaceuticals Inc | REGN | 5 697 799 | 2.4 | 9 936 |
| Harmony Biosciences Holdings Inc | HRMY | 5 687 588 | 2.4 | 194 381 |
| Jazz Pharmaceuticals PLC | JAZZ | 5 663 428 | 2.4 | 51 467 |
| Travere Therapeutics Inc | TVTX | 5 218 093 | 2.2 | 348 105 |
| Viatris Inc | VTRS | 4 771 377 | 2.0 | 626 165 |
| Geron Corp | GERN | 4 184 066 | 1.8 | 3 031 932 |
| Invesco Government & Agency Portfolio | AGPXX | 250 584 | 0.1 | 250 584 |